Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.454
Filter
2.
Exp Clin Transplant ; 22(Suppl 4): 33-36, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38775695

ABSTRACT

In Egypt, there is presently a growing need to have a deceased donor transplant program. Egypt conducted its first kidney transplant from a living donor in 1976 and a first partial liver transplant in 2001. Since 2009, the Egyptian Health Authorities Combat Transplant Tourism in concordance with ethics codes and the Declaration of Istanbul Custodian Group has been in place. The Egyptian Transplantation Law of 2011 mentions that organs could be procured from deceased donors based on a will and on family consent. This law has had many critics, including religious authorities who have stressed that organs cannot be taken from a person with brain death because, in their view, life ends with death of all organs. Many intensivists disagree over the definition of death. In addition, the media has communicated contradicting and sometimes misleading health care information. Mummification is rooted in pharos practice and linked to religious beliefs. The ancient Egyptians believed that, by burying the deceased with their organs, they may rejoin with them in the afterlife. Since 2019, the transplant community in Egypt has started collaborations with international transplant organizations and campaigns with doctors and celebrities to donate their organs after death, which have stressed that a deceased donor program could help against end-stage organ mortality. In November 2022, after communications with politicians, President Abdelfattah El Sisi directed the government to establish a regional center for organ transplantation, which aimed to be the biggest in the Middle East and North Africa region. The new center will be part of a new medical city that would replace Nasser Medical Institution in Cairo, Egypt. The Ministry of Health issued an official form to be signed by a person before his death, accepting use of organs, to give hope and support to other patients in need.


Subject(s)
Organ Transplantation , Tissue Donors , Tissue and Organ Procurement , Humans , Egypt , Organ Transplantation/legislation & jurisprudence , Organ Transplantation/ethics , Tissue Donors/supply & distribution , Tissue Donors/legislation & jurisprudence , Tissue and Organ Procurement/legislation & jurisprudence , Religion and Medicine , Medical Tourism/legislation & jurisprudence , Medical Tourism/ethics , Health Knowledge, Attitudes, Practice , Attitude to Death , Brain Death , Policy Making , Government Regulation , Informed Consent/legislation & jurisprudence
3.
Exp Clin Transplant ; 22(Suppl 4): 28-32, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38775694

ABSTRACT

The first living donor kidney transplant in Syria was performed 44 years ago; by the end of 2022, 6265 renal transplants had been performed in Syria. Kidney, bone marrow, cornea, and stem cells are the only organs or tissues that can be transplanted in Syria. Although 3 heart transplants from deceased donors were performed in the late 1980s, cardiac transplant activities have since discontinued. In 2003, national Syrian legislation was enacted authorizing the use of organs from living unrelated and deceased donors. This important law was preceded by another big stride: the acceptance by the higher Islamic religious authorities in Syria in 2001 of the principle of procurement of organs from deceased donors, provided that consent is given by a first- or second-degree relative. After the law was enacted, kidney transplant rates increased from 7 per million population in 2002 to 17 per million population in 2007. Kidney transplants performed abroad for Syrian patients declined from 25% in 2002 to <2% in 2007. Rates plateaued through 2010, before the political crisis started in 2011. Forty-four years after the first successful kidney transplant in Syria, patients needing an organ transplant rely on living donors only. Moreover, 20 years after the law authorizing use of organs from deceased donors, a program is still not in place in Syria. The war, limited resources, and lack of public awareness about the importance of organ donation and transplant appear to be factors inhibiting initiation of a deceased donor program in Syria. A concerted and ongoing education campaign is needed to increase awareness of organ donation, change negative public attitudes, and gain societal acceptance. Every effort must be made to initiate a deceased donor program to lessen the burden on living donors and to enable national self-sufficiency in organs for transplant.


Subject(s)
Living Donors , Organ Transplantation , Tissue Donors , Tissue and Organ Procurement , Humans , Syria , Tissue and Organ Procurement/legislation & jurisprudence , Tissue and Organ Procurement/trends , Organ Transplantation/legislation & jurisprudence , Organ Transplantation/trends , Living Donors/supply & distribution , Living Donors/legislation & jurisprudence , Tissue Donors/supply & distribution , Tissue Donors/legislation & jurisprudence , Religion and Medicine , Kidney Transplantation/legislation & jurisprudence , Islam , Time Factors , Health Policy/legislation & jurisprudence , Government Regulation
6.
Klin Monbl Augenheilkd ; 241(4): 412-416, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38653295

ABSTRACT

PURPOSE: To establish a national consensus on contraindications for corneal donation for transplantation in Switzerland. METHODS: Swisstransplant (SWT), the Swiss national foundation coordinating tissue and organ donations, convened a working group consisting of six national corneal surgeons and eye bankers and donation experts to create a contraindication list for corneal donation. The group reviewed available national and international guidelines and recommendations, while adhering to Swiss law and transplant regulations. In cases of opposing opinions, the group held follow-up meetings until a consensus was reached. A consensus was defined as agreement among all parties present. RESULTS: From March 2021 to November 2021, the study group held six meetings and created a standardized minimal contraindication list for corneal donation in Switzerland. Thanks to this list, SWT has created a mandatory working and documentation file for donor coordinators to use when evaluating multiorgan donors for corneal harvesting. The authors agreed that while the national consensus list provides standardized minimal contraindication criteria, local eye banks may choose to introduce additional, more rigorous criteria. CONCLUSION: Given that corneal transplantation is the most commonly performed transplantation, establishing a consensus on contraindications is crucial for recipient safety. The creation of a consensus on contraindications for corneal donation in Switzerland is an essential contribution to fulfil the legal requirements concerning quality assurance and provides sufficient high-quality donor tissue within the country. Therefore, periodic review and revision of the consensus is considered critical.


Subject(s)
Corneal Transplantation , Tissue and Organ Procurement , Switzerland , Corneal Transplantation/legislation & jurisprudence , Humans , Tissue and Organ Procurement/legislation & jurisprudence , Tissue Donors/legislation & jurisprudence , Consensus , Eye Banks/legislation & jurisprudence , Contraindications, Procedure
8.
Curr Opin Organ Transplant ; 29(3): 212-218, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38483113

ABSTRACT

PURPOSE OF REVIEW: The adoption of brain death played a crucial role in the development of organ transplantation, but the concept has become increasingly controversial. This essay will explore the current state of the controversy and its implications for the field. RECENT DEVELOPMENTS: The brain death debate, long limited to the bioethics community, has in recent years burst into the public consciousness following several high-profile cases. This has culminated in the reevaluation of the Uniform Determination of Death Act (UDDA), which is in the process of being updated. Any change to the UDDA has the potential to significantly impact the availability of organs. SUMMARY: The current update to the UDDA introduces an element of uncertainty, one the brain death debate had not previously had.


Subject(s)
Brain Death , Organ Transplantation , Tissue and Organ Procurement , Humans , Organ Transplantation/ethics , Organ Transplantation/adverse effects , Tissue and Organ Procurement/ethics , Tissue and Organ Procurement/legislation & jurisprudence , Tissue Donors/supply & distribution , Tissue Donors/ethics
9.
Ann Anat ; 254: 152234, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38423228

ABSTRACT

BACKGROUND: The relevance of anatomical dissection in instructing anatomy to medical, dental, and other health science students is indisputable. Ethiopian anatomists encountered challenges in obtaining human bodies for anatomy education and research, both prior to and following the COVID-19 outbreak. The challenges intensified during the pandemic, significantly affecting anatomy education in Ethiopia. This study seeks to investigate the sources of bodies for anatomy, spanning the periods before and after COVID-19, with a particular focus on identifying the primary challenges associated with sourcing of bodies in Ethiopia. METHODS: Fifty (50) anatomists completed a survey distributed to ten (10) randomly chosen medical institutions in Ethiopia. The survey gathered information on the body profile (number of bodies, age, sex, sources, and methods of body disposal), and the challenges faced during the sourcing of bodies in the years 2018 and 2023. RESULTS: A total of sixty-three (63) bodies were used by the sampled medical institutions between 2018 and 2023 academic years. All (100%) of the bodies used were unclaimed human bodies. Most (66.7%) of these bodies were males. The majority (65.5%) of these bodies were sourced from Tikur Anbessa hospital in Addis Ababa. None (0%) of the sampled medical institutions had body donation programs. Disposal of human tissues encompassed various methods, including the retention of skeletons, prosection of vital organs, and burial of remaining tissues. Economic constraints and the absence of a legal framework document were the main challenges in acquiring bodies in the pre-pandemic period. The COVID-19 pandemic prevention policies and the civil war further exacerbated the challenges in sourcing of bodies for anatomy dissections during the post-pandemic period. CONCLUSION: The reliance on unclaimed human bodies for anatomy education and research in Ethiopian medical institutions mirrors a common practice across many African countries. The authors suggest the development of a legislative framework or operational guidelines, coupled with empowering the medical institutions to outsource their own funding that will ultimately lead to an increased number of bodies available for anatomical dissection. Over time, implementation and promotion of body donation programs may also resolve body shortages for anatomy education in Ethiopia.


Subject(s)
Anatomy , COVID-19 , Cadaver , Pandemics , SARS-CoV-2 , COVID-19/epidemiology , Humans , Ethiopia , Anatomy/education , Male , Female , Adult , Dissection/education , Tissue and Organ Procurement/legislation & jurisprudence , Tissue and Organ Procurement/statistics & numerical data , Surveys and Questionnaires , Young Adult , Middle Aged , Pneumonia, Viral/epidemiology , Coronavirus Infections/epidemiology
10.
Transplantation ; 108(6): 1430-1439, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38277264

ABSTRACT

BACKGROUND: Since 2014, as part of a priority program within the Israeli Transplant Law, additional points were given to waitlisted candidates with donor cards. We assessed the impact on deceased donor kidney allocation. METHODS: This study enrolled all patients older than 18 y who underwent deceased donor kidney transplantation (January 2016-December 2019). Data were obtained from the National HLA Tissue Laboratory registry at the Sheba Medical Center. Patients were grouped by donor card status (ADI group) (not signed, 0 points; relative signed, 0.1 points; patient signed, 2 points; and relative donated, 9 points). The primary outcome was waiting time until kidney transplantation with and without the additional score. RESULTS: Four hundred forty-four patients underwent kidney transplantation during the study period: 281 (63%) were donor card holders (DCH) and 163 (37%) were not DCH. DCH with extra points waited 68.0 (±47.0) mo on average, compared with 94.6 (±47.3) mo for not DCH ( P  < 0.001). Donor card signers had a shorter time until transplant in a multivariable model. Without extra points, 145 recipients (32.6%) would have missed organs allocated to higher-scored candidates. Allocation changes occurred in 1 patient because of an additional 0.1 points, in 103 candidates because of an additional 2 points, and in 41 candidates because of an additional 9 points. CONCLUSIONS: Additional DCH scores improved allocation and reduced waiting time for donor card signers and those with donating relatives. To enhance fairness, consideration should be given to reducing the score weight of this social criterion and raising scores for other factors, especially dialysis duration.


Subject(s)
Kidney Transplantation , Tissue Donors , Waiting Lists , Humans , Male , Israel , Female , Middle Aged , Tissue Donors/supply & distribution , Adult , Tissue and Organ Procurement/legislation & jurisprudence , Tissue and Organ Procurement/organization & administration , Registries , Time Factors , Aged , Donor Selection , Retrospective Studies , Time-to-Treatment
11.
JAMA ; 330(24): 2335-2336, 2023 12 26.
Article in English | MEDLINE | ID: mdl-38060232

ABSTRACT

This Viewpoint summarizes the major issues that led to the decision to draft a revision of the Uniform Determination of Death Act, the alternatives that were considered, why there was failure to reach consensus, and what this means for the future.


Subject(s)
Brain Death , Humans , Brain Death/diagnosis , Brain Death/legislation & jurisprudence , Brain Death/physiopathology , Death , Tissue and Organ Procurement/legislation & jurisprudence , United States
12.
JAMA Netw Open ; 6(9): e2332395, 2023 09 05.
Article in English | MEDLINE | ID: mdl-37672275

ABSTRACT

This cohort study examines changes in research pancreas procurement from deceased donors before and after the Centers for Medicare & Medicaid Services (CMS) updated its Final Rule in November 2020.


Subject(s)
Pancreas , Tissue and Organ Procurement , Humans , Centers for Medicare and Medicaid Services, U.S. , United States , Tissue and Organ Procurement/legislation & jurisprudence
13.
Anaesthesiologie ; 72(1): 67-78, 2023 01.
Article in German | MEDLINE | ID: mdl-36637499

ABSTRACT

The prerequisites for post-mortem organ donation in Germany include the determination of irreversible loss of brain function, consent to organ donation, and the exclusion of medical contraindications. In addition, mainly because of the shortage of donor organs in Germany and the sometimes controversial social and media discussions on the topic of organ donation, all physicians involved in the donation process must be familiar with the relevant laws, guidelines, and procedural instructions. This applies especially to those who are to carry out the verification of irreversible brain death. Only then, can they act safely in this challenging situation and serve as competent consultants for all involved.


Subject(s)
Brain Death , Tissue and Organ Procurement , Humans , Brain Death/diagnosis , Informed Consent/legislation & jurisprudence , Tissue and Organ Harvesting/legislation & jurisprudence , Tissue and Organ Procurement/legislation & jurisprudence , Tissue and Organ Procurement/methods , Germany
14.
J Thorac Cardiovasc Surg ; 163(1): 339-345, 2022 01.
Article in English | MEDLINE | ID: mdl-33008575

ABSTRACT

OBJECTIVE: On November 24, 2017, Organ Procurement and Transplantation Network implemented a change to lung allocation replacing donor service area with a 250 nautical mile radius around donor hospitals. We sought to evaluate the experience of a small to medium size center following implementation. METHODS: Patients (47 pre and 54 post) undergoing lung transplantation were identified from institutional database from January 2016 to October 2019. Detailed chart review and analysis of institutional cost data was performed. Univariate analysis was performed to compare eras. RESULTS: Similar short-term mortality and primary graft dysfunction were observed between groups. Decreased local donation (68% vs 6%; P < .001), increased travel distance (145 vs 235 miles; P = .004), travel cost ($8626 vs $14,482; P < .001), and total procurement cost ($60,852 vs $69,052; P = .001) were observed postimplementation. We also document an increase in waitlist mortality postimplementation (6.9 vs 31.6 per 100 patient-years; P < .001). CONCLUSIONS: Following implementation of the new allocation policy in a small to medium size center, several changes were in accordance with policy intention. However, concerning shifts emerged, including increased waitlist mortality and resource utilization. Continued close monitoring of transplant centers stratified by size and location are paramount to maintaining global availability of lung transplantation to all Americans regardless of geographic residence or socioeconomic status.


Subject(s)
Health Services Accessibility/statistics & numerical data , Lung Diseases , Lung Transplantation , Resource Allocation , Tissue and Organ Procurement , Waiting Lists/mortality , Databases, Factual/statistics & numerical data , Female , Graft Rejection/epidemiology , Hospitals, Low-Volume/economics , Hospitals, Low-Volume/statistics & numerical data , Humans , Lung Diseases/classification , Lung Diseases/mortality , Lung Diseases/surgery , Lung Transplantation/methods , Lung Transplantation/statistics & numerical data , Male , Middle Aged , Mortality , Needs Assessment , Organizational Innovation , Resource Allocation/methods , Resource Allocation/organization & administration , Resource Allocation/trends , Tissue Donors , Tissue and Organ Procurement/economics , Tissue and Organ Procurement/legislation & jurisprudence , Tissue and Organ Procurement/trends , United States/epidemiology
15.
BJOG ; 129(4): 590-596, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34532958

ABSTRACT

Uterus transplantation (UTx) is fast evolving from an experimental to a clinical procedure, combining solid organ transplantation with assisted reproductive technology. The commencement of the first human uterus transplant trial in the United Kingdom leads us to examine and reflect upon the legal and regulatory aspects closely intertwined with UTx from the process of donation to potential implications for fertility treatment and the birth of the resultant child. As the world's first ephemeral transplant, the possibility of organ restitution requires consideration and is discussed herein. TWEETABLE ABSTRACT: Uterine transplantation warrants a closer look at the legal frameworks on fertility treatment and transplantation in England.


Subject(s)
Organ Transplantation/legislation & jurisprudence , Uterus/transplantation , England , Female , Humans , Hysterectomy/legislation & jurisprudence , Hysterectomy/psychology , Reproductive Techniques, Assisted/legislation & jurisprudence , Tissue and Organ Procurement/legislation & jurisprudence
SELECTION OF CITATIONS
SEARCH DETAIL
...